Solasia Pharma K.K. (TYO:4597)
31.00
-3.00 (-8.82%)
Mar 10, 2026, 9:04 AM JST
Solasia Pharma K.K. Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -876 | -1,961 | -1,135 | -2,492 | -2,442 | Upgrade
|
| Depreciation & Amortization | 37 | 195 | 500 | 534 | 495 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 959 | - | 431 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 1 | 4 | 5 | 3 | - | Upgrade
|
| Other Operating Activities | 10 | -6 | -36 | -12 | -2 | Upgrade
|
| Change in Accounts Receivable | -142 | -164 | 540 | -446 | 51 | Upgrade
|
| Change in Inventory | 15 | -5 | -108 | -14 | 4 | Upgrade
|
| Change in Accounts Payable | 108 | -92 | -118 | -65 | -626 | Upgrade
|
| Change in Other Net Operating Assets | - | 37 | -7 | -13 | 47 | Upgrade
|
| Operating Cash Flow | -847 | -1,033 | -359 | -2,074 | -2,473 | Upgrade
|
| Capital Expenditures | - | -1 | - | - | -2 | Upgrade
|
| Cash Acquisitions | - | - | - | -14 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -403 | -161 | Upgrade
|
| Investment in Securities | -77 | - | - | - | - | Upgrade
|
| Other Investing Activities | -4 | 1 | - | -1 | -1 | Upgrade
|
| Investing Cash Flow | -81 | - | - | -418 | -164 | Upgrade
|
| Long-Term Debt Issued | - | 500 | - | 500 | - | Upgrade
|
| Long-Term Debt Repaid | -32 | -500 | - | -500 | -1,000 | Upgrade
|
| Net Debt Issued (Repaid) | -32 | - | - | - | -1,000 | Upgrade
|
| Issuance of Common Stock | 1,458 | 1,215 | 318 | 2,621 | 1,403 | Upgrade
|
| Other Financing Activities | -1 | -35 | -43 | -50 | -42 | Upgrade
|
| Financing Cash Flow | 1,425 | 1,180 | 275 | 2,571 | 361 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5 | 11 | 7 | 10 | 25 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -1 | 1 | -1 | 1 | Upgrade
|
| Net Cash Flow | 502 | 157 | -76 | 88 | -2,250 | Upgrade
|
| Free Cash Flow | -847 | -1,034 | -359 | -2,074 | -2,475 | Upgrade
|
| Free Cash Flow Margin | -197.44% | -327.21% | -58.18% | -189.93% | -442.75% | Upgrade
|
| Free Cash Flow Per Share | -3.57 | -5.20 | -2.13 | -13.65 | -19.02 | Upgrade
|
| Cash Interest Paid | 1 | 1 | - | 1 | 1 | Upgrade
|
| Cash Income Tax Paid | - | 1 | 25 | 28 | 22 | Upgrade
|
| Levered Free Cash Flow | -518.63 | -1,252 | 62.13 | -1,949 | -1,667 | Upgrade
|
| Unlevered Free Cash Flow | -509.88 | -1,249 | 62.13 | -1,937 | -1,653 | Upgrade
|
| Change in Working Capital | -19 | -224 | 307 | -538 | -524 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.